Pancholy Samir B, Patel Purveshkumar, Patel Gaurav A, Patel Dhara D, Patel Neil R, Pattara Elizabeth A, Patel Tejas M
The Wright Center for Graduate Medical Education, Scranton, PA, USA.
Apex Heart Institute, Ahmedabad, India.
Int J Cardiol Heart Vasc. 2021 Sep 22;36:100878. doi: 10.1016/j.ijcha.2021.100878. eCollection 2021 Oct.
Association of history of coronary artery bypass graft surgery (CABG) with clinical outcomes in patients presenting with ST-segment elevation myocardial infarction (STEMI) is unclear from current data.
Using Nationwide Inpatient Sample (NIS) data from 2003 to 2014, adult patients hospitalized with principal diagnosis of STEMI were extracted. The cohort was divided into patients with a history of CABG and those without a history of CABG. The primary outcome measure was in-hospital mortality (IHM).
2,710,375 STEMI patients were included in final analysis of which 110,066 had history of CABG. Patients with history of CABG had higher unadjusted (12.2% vs. 8.8%, < 0.001) and adjusted (odds ratio [OR]1.16; 95% confidence interval [CI] 1.14 to1.19, < 0.001) IHM compared to those without previous CABG. Compared to a trend of decreasing IHM in STEMI patients without previous CABG, a trend of increasing IHM was observed over the study period in those with a history of previous CABG. Although patients with previous CABG when treated with primary PCI (PPCI) had a higher unadjusted IHM compared to those without previous CABG, (4.8% vs 4.3%, < 0.001), after adjusting for comorbidities and in-hospital complications no significant increase in IHM was observed in patients with previous CABG treated with PPCI.
STEMI patients with previous CABG have a significantly higher IHM compared to those without previous CABG. PPCI improves IHM with no independent mortality disadvantage attributable to previous CABG.
目前的数据尚不清楚冠状动脉旁路移植术(CABG)史与ST段抬高型心肌梗死(STEMI)患者临床结局之间的关联。
利用2003年至2014年的全国住院患者样本(NIS)数据,提取主要诊断为STEMI的成年住院患者。该队列分为有CABG史的患者和无CABG史的患者。主要结局指标是住院死亡率(IHM)。
2710375例STEMI患者纳入最终分析,其中110066例有CABG史。有CABG史的患者未经调整的IHM较高(12.2%对8.8%,P<0.001),经调整后(比值比[OR]为1.16;95%置信区间[CI]为1.14至1.19,P<0.001)也高于无CABG史的患者。与无CABG史的STEMI患者IHM呈下降趋势相比,在研究期间,有CABG史的患者IHM呈上升趋势。尽管有CABG史的患者接受直接经皮冠状动脉介入治疗(PPCI)时未经调整的IHM高于无CABG史的患者(4.8%对4.3%,P<0.001),但在调整合并症和住院并发症后,接受PPCI治疗的有CABG史患者的IHM没有显著增加。
有CABG史的STEMI患者的IHM显著高于无CABG史的患者。PPCI可改善IHM,既往CABG不会导致独立的死亡劣势。